1
TITLE: Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance
AUTHORS: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; Delwail, Vincent; Pica, Gian Matteo; Martin Garcia Sancho, Alejandro; Lopez Guillermo, Armando; Larouche, Jean Francois; Ando, Kiyoshi; Maria, Gomes da Silva; Andre, Marc; Wu, Ka Lung; Sehn, Laurie H.; Izutsu, Koji; Cartron, Guillaume; Gkasiamis, Argyrios; Crowe, Russell; Xerri, Luc; Fowler, Nathan H.; Salles, Gilles; ...More
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138
INDEXED IN: WOS
2
TITLE: Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
AUTHORS: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLISHED: 2018, SOURCE: LANCET HAEMATOLOGY, VOLUME: 5, ISSUE: 9
INDEXED IN: Scopus WOS
3
TITLE: Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
AUTHORS: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 22
INDEXED IN: Scopus WOS CrossRef
4
TITLE: Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial  Full Text
AUTHORS: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; Catherine Sebban; Andrew Lister; Jane A Estell; Gustavo Milone; Anne Sonet; Myriam Mendila; Bertrand Coiffier; Herve Tilly; ...More
PUBLISHED: 2011, SOURCE: LANCET, VOLUME: 377, ISSUE: 9759
INDEXED IN: Scopus WOS CrossRef